NCT03260595View on ClinicalTrials.gov

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions
HealthyAtopic Dermatitis
Interventions
DRUG

Crisaborole ointment 2%

Crisaborole ointment 2%

DRUG

Vehicle

Vehicle

Trial Locations (1)

532-0003

Medical Corporation Heishinkai OPHAC Hospital, Osaka

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY